Structural basis of Cas3 activation in type I-C CRISPR-Cas system

被引:1
|
作者
Kim, Do Yeon [1 ,2 ]
Lee, So Yeon [1 ,2 ]
Ha, Hyun Ji [1 ]
Park, Hyun Ho [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Global Innovat Drugs, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
PROVIDES ACQUIRED-RESISTANCE; INTERFERENCE; BACTERIA; NUCLEASE; INSIGHTS; IMMUNITY; HELICASE; TOOL;
D O I
10.1093/nar/gkae723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas systems function as adaptive immune mechanisms in bacteria and archaea and offer protection against phages and other mobile genetic elements. Among many types of CRISPR-Cas systems, Type I CRISPR-Cas systems are most abundant, with target interference depending on a multi-subunit, RNA-guided complex known as Cascade that recruits a transacting helicase nuclease, Cas3, to degrade the target. While structural studies on several other types of Cas3 have been conducted long ago, it was only recently that the structural study of Type I-C Cas3 in complex with Cascade was revealed, shedding light on how Cas3 achieve its activity in the Cascade complex. In the present study, we elucidated the first structure of standalone Type I-C Cas3 from Neisseria lactamica (NlaCas3). Structural analysis revealed that the histidine-aspartate (HD) nuclease active site of NlaCas3 was bound to two Fe2+ ions that inhibited its activity. Moreover, NlaCas3 could cleave both single-stranded and double-stranded DNA in the presence of Ni2+ or Co2+, showing the highest activity in the presence of both Ni2+ and Mg2+ ions. By comparing the structural studies of various Cas3 proteins, we determined that our NlaCas3 stays in an inactive conformation, allowing us to understand the structural changes associated with its activation and their implication. Graphical Abstract
引用
收藏
页码:10563 / 10574
页数:12
相关论文
共 50 条
  • [41] Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases
    Molina, Rafael
    Jensen, Anne Louise Gron
    Marchena-Hurtado, Javier
    Lopez-Mendez, Blanca
    Stella, Stefano
    Montoya, Guillermo
    NUCLEIC ACIDS RESEARCH, 2021, 49 (21) : 12577 - 12590
  • [42] The CRISPR-Cas system in molecular diagnostics
    Song, Rao
    Chen, Zhongyi
    Xiao, Hongtao
    Wang, Haojun
    CLINICA CHIMICA ACTA, 2024, 561
  • [43] Therapeutic Applications of the CRISPR-Cas System
    Kang, Kyungmin
    Song, Youngjae
    Kim, Inho
    Kim, Tae-Jung
    BIOENGINEERING-BASEL, 2022, 9 (09):
  • [44] Programmable CRISPR-Cas transcriptional activation in bacteria
    Ho, Hsing-, I
    Fang, Jennifer R.
    Cheung, Jacky
    Wang, Harris H.
    MOLECULAR SYSTEMS BIOLOGY, 2020, 16 (07)
  • [45] Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3
    Wang, Xiaofei
    Yao, Deqiang
    Xu, Jin-Gen
    Li, A-Rong
    Xu, Jianpo
    Fu, Panhan
    Zhou, Yan
    Zhu, Yongqun
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2016, 23 (09) : 868 - 870
  • [46] Efficient, compact, and versatile: Type I-F2 CRISPR-Cas system
    Ma, Shengsheng
    Zhang, Senfeng
    Liu, Kunming
    Hu, Tao
    Hu, Chunyi
    MLIFE, 2024, 3 (03): : 384 - 386
  • [47] Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus
    Hidalgo-Cantabrana, Claudio
    Goh, Yong Jun
    Pan, Meichen
    Sanozky-Dawes, Rosemary
    Barrangou, Rodolphe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (32) : 15774 - 15783
  • [48] Dynamic interplay between target search and recognition for a Type I CRISPR-Cas system
    Pierre Aldag
    Marius Rutkauskas
    Julene Madariaga-Marcos
    Inga Songailiene
    Tomas Sinkunas
    Felix Kemmerich
    Dominik Kauert
    Virginijus Siksnys
    Ralf Seidel
    Nature Communications, 14
  • [49] Dynamic interplay between target search and recognition for a Type I CRISPR-Cas system
    Aldag, Pierre
    Rutkauskas, Marius
    Madariaga-Marcos, Julene
    Songailiene, Inga
    Sinkunas, Tomas
    Kemmerich, Felix
    Kauert, Dominik
    Siksnys, Virginijus
    Seidel, Ralf
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [50] Interference activity of a minimal Type I CRISPR-Cas system from Shewanella putrefaciens
    Dwarakanath, Srivatsa
    Brenzinger, Susanne
    Gleditzsch, Daniel
    Plagens, Andre
    Klingl, Andreas
    Thormann, Kai
    Randau, Lennart
    NUCLEIC ACIDS RESEARCH, 2015, 43 (18) : 8913 - 8923